ArticleJournal of clinical medicine2026

Bevacizumab-Based Therapy Is Associated with Prolonged Progression-Free Survival in Patients with Peritoneal Mucinous Metastatic Colorectal Cancer.

Süleyman Can et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.